HRT Financial’s Nanobiotix NBTX Stock Holding History

HRT Financial’s Portfolio NBTX Stock Details NBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.03M	Buy	+27,332	New	+$1.02M	﹤0.01%	2160

Other funds holding NBTX

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

HRT Financial's NBTX Position: Q2 2026 in Review

HRT Financial opened a new position in Nanobiotix (NBTX) in Q2 2026: 27,332 shares worth $1.03M. The stake represents ﹤0.01% of the portfolio and ranks #2160 among its holdings.

19 funds tracked by Wall St. Rank hold NBTX as of Q2 2026.

HRT Financial held 27,332 shares of Nanobiotix worth $1.03M as of Q2 2026.
Nanobiotix was a new HRT Financial position in Q2 2026.
Nanobiotix made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2160 holding.
19 funds tracked by Wall St. Rank held Nanobiotix as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.